AML1, the Target of Multiple Chromosomal Translocations in Human Leukemia, Is Essential for Normal Fetal Liver Hematopoiesis
暂无分享,去创建一个
J. Downing | G. Grosveld | S. Hiebert | J. Deursen | James R Downing | Jan van Deursen | Scott W Hiebert | T. Okuda | Gerard Grosveld | Tsukasa Okuda
[1] F. Collins,et al. Fusion between transcription factor CBF beta/PEBP2 beta and a myosin heavy chain in acute myeloid leukemia. , 1993, Science.
[2] Y. Yazaki,et al. Generation of the AML1‐EVI‐1 fusion gene in the t(3;21)(q26;q22) causes blastic crisis in chronic myelocytic leukemia. , 1994, The EMBO journal.
[3] C. Wijmenga,et al. Molecular pathogenesis of the chromosome 16 inversion in the M4Eo subtype of acute myeloid leukemia. , 1995, Blood.
[4] E. Wieschaus,et al. Dosage requirements for runt in the segmentation of Drosophila embryos , 1986, Cell.
[5] J. Ihle. Interleukin-3 and Hematopoiesis (Part 1 of 2) , 1992 .
[6] S. Burden,et al. AML1 is expressed in skeletal muscle and is regulated by innervation , 1994, Molecular and cellular biology.
[7] Y. Ito,et al. PEBP2/PEA2 represents a family of transcription factors homologous to the products of the Drosophila runt gene and the human AML1 gene. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[8] R. Lovell-Badge,et al. Modulation of gene activity by consecutive gene targeting of one creatine kinase M allele in mouse embryonic stem cells. , 1991, Nucleic acids research.
[9] A. Emery,et al. Genetic variability , 1980, Nature.
[10] P. Gruss,et al. Multiple point mutations affecting the simian virus 40 enhancer. , 1983, Science.
[11] I. Bar-Am,et al. AML1, AML2, and AML3, the human members of the runt domain gene-family: cDNA structure, expression, and chromosomal localization. , 1994, Genomics.
[12] Stuart H. Orkin,et al. Transcription Factors and Hematopoietic Development (*) , 1995, The Journal of Biological Chemistry.
[13] J. Lenz,et al. Relative importance of elements within the SL3-3 virus enhancer for T-cell specificity , 1990, Journal of virology.
[14] C. A. Thomas,et al. Molecular cloning. , 1977, Advances in pathobiology.
[15] D C Ward,et al. Fusion of the TEL gene on 12p13 to the AML1 gene on 21q22 in acute lymphoblastic leukemia. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[16] R. Hromas,et al. Transcriptional regulation of interleukin 3 gene expression in T lymphocytes. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[17] Y. Ito,et al. Purification of a mouse nuclear factor that binds to both the A and B cores of the polyomavirus enhancer , 1990, Journal of virology.
[18] S. Shurtleff,et al. Heterogeneity in CBF beta/MYH11 fusion messages encoded by the inv(16)(p13q22) and the t(16;16)(p13;q22) in acute myelogenous leukemia. , 1995, Blood.
[19] R. Weinberg,et al. Extensive contribution of Rb‐deficient cells to adult chimeric mice with limited histopathological consequences. , 1994, The EMBO journal.
[20] F. Collins,et al. Overexpression of core-binding factor alpha (CBF alpha) reverses cellular transformation by the CBF beta-smooth muscle myosin heavy chain chimeric oncoprotein , 1995, Molecular and cellular biology.
[21] J. Lenz,et al. Identification of the SL3-3 virus enhancer core as a T-lymphoma cell-specific element , 1989, Journal of virology.
[22] S. Shurtleff,et al. TEL/AML1 fusion resulting from a cryptic t(12;21) is the most common genetic lesion in pediatric ALL and defines a subgroup of patients with an excellent prognosis. , 1995, Leukemia.
[23] S Meyers,et al. PEBP2/CBF, the murine homolog of the human myeloid AML1 and PEBP2 beta/CBF beta proto-oncoproteins, regulates the murine myeloperoxidase and neutrophil elastase genes in immature myeloid cells , 1994, Molecular and cellular biology.
[24] P. Landrigan. Childhood leukemias. , 1995, The New England journal of medicine.
[25] M. Ohki,et al. The Runt domain identifies a new family of heteromeric transcriptional regulators. , 1993, Trends in genetics : TIG.
[26] J. Ihle,et al. Interleukin-3 and hematopoiesis. , 1992, Chemical immunology.
[27] B. Wieringa,et al. Genetic variability of the murine creatine kinase B gene locus and related pseudogenes in different inbred strains of mice. , 1992, Genomics.
[28] J. Rowley,et al. AML1 and the 8;21 and 3;21 translocations in acute and chronic myeloid leukemia. , 1995, Blood.
[29] N. Speck,et al. Cooperative binding of Ets-1 and core binding factor to DNA , 1994, Molecular and cellular biology.
[30] E. Soeda,et al. Alternative splicing and genomic structure of the AML1 gene involved in acute myeloid leukemia. , 1995, Nucleic acids research.
[31] H. Prosser,et al. A phorbol ester response element within the human T-cell receptor beta-chain enhancer. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[32] E. Scott,et al. Requirement of transcription factor PU.1 in the development of multiple hematopoietic lineages. , 1994, Science.
[33] J. Redondo,et al. Indistinguishable nuclear factor binding to functional core sites of the T-cell receptor delta and murine leukemia virus enhancers. , 1992, Molecular and cellular biology.
[34] E. Wieschaus,et al. The localized requirements for a gene affecting segmentation in Drosophila: analysis of larvae mosaic for runt. , 1985, Developmental biology.
[35] A. Look,et al. Identification of a region which directs the monocytic activity of the colony-stimulating factor 1 (macrophage colony-stimulating factor) receptor promoter and binds PEBP2/CBF (AML1) , 1994, Molecular and cellular biology.
[36] J. Rowley,et al. Consistent intergenic splicing and production of multiple transcripts between AML1 at 21q22 and unrelated genes at 3q26 in (3;21)(q26;q22) translocations. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[37] G. Keller,et al. Rescue of erythroid development in gene targeted GATA–1− mouse embryonic stem cells , 1992, Nature Genetics.
[38] N. Lenny,et al. The t(8;21) fusion protein interferes with AML-1B-dependent transcriptional activation , 1995, Molecular and cellular biology.
[39] G. Keller,et al. Novel insights into erythroid development revealed through in vitro differentiation of GATA-1 embryonic stem cells. , 1994, Genes & development.
[40] D. Le Paslier,et al. The t(12;21) of acute lymphoblastic leukemia results in a tel-AML1 gene fusion. , 1995, Blood.
[41] J. Downing,et al. An AML1/ETO fusion transcript is consistently detected by RNA-based polymerase chain reaction in acute myelogenous leukemia containing the (8;21)(q22;q22) translocation. , 1993, Blood.
[42] F. Collins,et al. The leukemic core binding factor beta-smooth muscle myosin heavy chain (CBF beta-SMMHC) chimeric protein requires both CBF beta and myosin heavy chain domains for transformation of NIH 3T3 cells. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[43] G. Dranoff,et al. Involvement of granulocyte-macrophage colony-stimulating factor in pulmonary homeostasis. , 1994, Science.
[44] B. Wieringa,et al. Targeting of the creatine kinase M gene in embryonic stem cells using isogenic and nonisogenic vectors. , 1992, Nucleic acids research.
[45] M. Ohki,et al. t(8;21) breakpoints on chromosome 21 in acute myeloid leukemia are clustered within a limited region of a single gene, AML1. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[46] Stuart H. Orkin,et al. An early haematopoietic defect in mice lacking the transcription factor GATA-2 , 1994, Nature.
[47] P. Watkins,et al. Transcriptionally active chimeric gene derived from the fusion of the AML1 gene and a novel gene on chromosome 8 in t(8;21) leukemic cells. , 1992, Cancer genetics and cytogenetics.
[48] S. Hiebert,et al. Indirect and direct disruption of transcriptional regulation in cancer: E2F and AML-1. , 1995, Critical reviews in eukaryotic gene expression.
[49] J. Rowley,et al. The 3;21 translocation in myelodysplasia results in a fusion transcript between the AML1 gene and the gene for EAP, a highly conserved protein associated with the Epstein-Barr virus small RNA EBER 1. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[50] S. Misawa,et al. Actions of human interleukin-4/B-cell stimulatory factor-1 on proliferation and differentiation of enriched hematopoietic progenitor cells in culture. , 1990, Blood.
[51] S. Swerdlow,et al. A functional c-myb gene is required for normal murine fetal hepatic hematopoiesis , 1991, Cell.
[52] Yoshiaki Ito,et al. Molecular Cloning and Characterization of PEBP2β, the Heterodimeric Partner of a Novel Drosophila runt-Related DNA Binding Protein PEBP2α , 1993 .
[53] M. Wiles,et al. Hematopoietic commitment during embryonic stem cell differentiation in culture. , 1993, Molecular and cellular biology.
[54] H. Drabkin,et al. Identification of breakpoints in t(8;21) acute myelogenous leukemia and isolation of a fusion transcript, AML1/ETO, with similarity to Drosophila segmentation gene, runt. , 1992, Blood.
[55] A. Smith,et al. Buffalo rat liver cells produce a diffusible activity which inhibits the differentiation of murine embryonal carcinoma and embryonic stem cells. , 1987, Developmental biology.
[56] J. Downing,et al. Identification of AML-1 and the (8;21) translocation protein (AML-1/ETO) as sequence-specific DNA-binding proteins: the runt homology domain is required for DNA binding and protein-protein interactions , 1993, Molecular and cellular biology.
[57] N. Manley,et al. Two factors that bind to highly conserved sequences in mammalian type C retroviral enhancers , 1993, Journal of virology.
[58] A. Dunn,et al. Granulocyte/macrophage colony-stimulating factor-deficient mice show no major perturbation of hematopoiesis but develop a characteristic pulmonary pathology. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[59] M. Ohki,et al. The t(8;21) translocation in acute myeloid leukemia results in production of an AML1‐MTG8 fusion transcript. , 1993, The EMBO journal.
[60] N. Speck,et al. Cloning and characterization of subunits of the T-cell receptor and murine leukemia virus enhancer core-binding factor , 1993, Molecular and cellular biology.
[61] M. Krangel,et al. c-Myb and core-binding factor/PEBP2 display functional synergy but bind independently to adjacent sites in the T-cell receptor delta enhancer , 1995, Molecular and cellular biology.
[62] Y. Yamaguchi-Iwai,et al. Isolation of PEBP2 alpha B cDNA representing the mouse homolog of human acute myeloid leukemia gene, AML1. , 1993, Oncogene.
[63] E. Macintyre,et al. High frequency of t(12;21) in childhood B-lineage acute lymphoblastic leukemia. , 1995, Blood.
[64] G. Keller,et al. Multiple hematopoietic lineages develop from embryonic stem (ES) cells in culture. , 1991, Development.
[65] C. Pui. Medical progress : childhood leukemias , 1995 .
[66] J. Gergen,et al. The Drosophila segmentation gene runt encodes a novel nuclear regulatory protein that is also expressed in the developing nervous system. , 1990, Genes & development.
[67] S. Nishikawa,et al. The murine mutation osteopetrosis is in the coding region of the macrophage colony stimulating factor gene , 1990, Nature.
[68] N. Speck,et al. Characterization of a protein that binds multiple sequences in mammalian type C retrovirus enhancers , 1993, Journal of virology.
[69] K. Arai,et al. Positive and negative regulation of granulocyte-macrophage colony-stimulating factor promoter activity by AML1-related transcription factor, PEBP2. , 1995, Blood.
[70] S. Orkin,et al. Erythroid differentiation in chimaeric mice blocked by a targeted mutation in the gene for transcription factor GATA-1 , 1991, Nature.
[71] C. Eaves,et al. Properties of the earliest clonogenic hemopoietic precursors to appear in the developing murine yolk sac. , 1986, Proceedings of the National Academy of Sciences of the United States of America.
[72] J. Gergen,et al. The Drosophila segmentation gene runt acts as a position-specific numerator element necessary for the uniform expression of the sex-determining gene Sex-lethal. , 1991, Genes & development.
[73] S. Shurtleff,et al. Frequent deletion of p16INK4a/MTS1 and p15INK4b/MTS2 in pediatric acute lymphoblastic leukemia. , 1995, Blood.
[74] N. Speck,et al. The role of viral enhancer "core" motif-related sequences in regulating T cell receptor-gamma and -delta gene expression. , 1993, Journal of immunology.
[75] S. Orkin,et al. Absence of blood formation in mice lacking the T-cell leukaemia oncoprotein tal-1/SCL , 1995, Nature.
[76] P. Sperryn,et al. Blood. , 1989, British journal of sports medicine.
[77] T. Rabbitts,et al. Chromosomal translocations in human cancer , 1994, Nature.
[78] M. Evans,et al. The Oncogenic Cysteine-rich LIM domain protein Rbtn2 is essential for erythroid development , 1994, Cell.
[79] F. Calabi,et al. Leukaemia/Drosophila homology , 1992, Nature.
[80] A. Dunn,et al. Mice lacking both macrophage- and granulocyte-macrophage colony-stimulating factor have macrophages and coexistent osteopetrosis and severe lung disease. , 1994, Blood.
[81] E. Golemis,et al. Mutation of the core or adjacent LVb elements of the Moloney murine leukemia virus enhancer alters disease specificity. , 1990, Genes & development.
[82] James Douglas Engel,et al. Targeted disruption of the GATA3 gene causes severe abnormalities in the nervous system and in fetal liver haematopoiesis , 1995, Nature Genetics.
[83] Y. Yamaguchi-Iwai,et al. Expression of the Runt domain-encoding PEBP2 alpha genes in T cells during thymic development , 1995, Molecular and cellular biology.